Screener
Nektar Therapeutics NKTR Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $3.4M-46.3% | $5.7M-20.0% | $3.2M-67.5% | $11.35M+81.7% | $6.33M-38.9% | ||
| $645.07M+385% | $419.03M+133% | $230.64M+9.3% | $229.18M+6.9% | $132.92M-45.4% | ||
| $739.4M+296% | $589.04M+156% | $266.27M+1.9% | $281.36M-1.8% | $186.57M-36.8% | ||
| $1.1B+428% | $763.27M+198% | $280.41M-7.7% | $301.35M-2.1% | $207.53M-39.6% | ||
| $24.89M+74.3% | $10.03M-43.8% | $10.77M-6.8% | $15.56M+81.5% | $14.28M+121% | ||
| $70.99M-0.6% | $57.71M-18.6% | $53.54M-12.8% | $66.34M-1.8% | $71.39M+24.5% | ||
| $192.01M-17.1% | $187.06M-22.9% | $190.57M-21.6% | $216.26M-16.5% | $231.75M-12.1% | ||
| 390M+30.0% | 390M+30.0% | 390M+38,999,900% | 390M+30.0% | 300M0.0% | ||
| -$3.85B-4.3% | -$3.81B-4.3% | -$3.76B-4.6% | -$3.72B-3.4% | -$3.69B-3.4% | ||
| $903.12M+3,830% | $576.22M+4,094% | $89.83M+47.9% | $85.09M+74.1% | -$24.21M-130% | ||
| $1.1B+428% | $763.27M+198% | $280.41M-7.7% | $301.35M-2.1% | $207.53M-39.6% |
FAQ
- What are Nektar Therapeutics's total assets?
- Nektar Therapeutics (NKTR) holds $1.1B in total assets, up 427.7% year over year.
- How much debt does Nektar Therapeutics have?
- Nektar Therapeutics carries $78.6M in total debt against $903.1M of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Nektar Therapeutics have?
- Nektar Therapeutics holds $3.4M in cash and equivalents.
- Can Nektar Therapeutics cover its short-term obligations?
- Its current ratio is 10.42 — current assets exceed current liabilities.
- Where does Nektar Therapeutics's balance sheet data come from?
- Every line is extracted from Nektar Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
